News
Shares of Dyne Therapeutics declined after the company commenced an underwritten public offering and said it had secured up to $275 million of debt financing. The stock fell 9.8% to $8.59 on Monday.
The market for new offerings has thawed recently, and everyday investors can participate in IPOs through several different ...
UC Asset LP (OTCQB: UCASU) announced today that the company has filed its first amendment to Form 1A for a secondary ...
A surge of global and domestic capital is chasing secondary deals as early-stage domestic funds are nearing the end of their ...
HONG Kong’s sizzling initial public offering (IPO) market is prompting the Big Four accounting firms to sharply raise their ...
4d
Startups.co.uk on MSNFounders are opting for partial exits amid economic uncertaintyA tougher investment climate in the wake of the pandemic means more business owners are opting for secondary transactions.
"Any transfer of OpenAI equity requires our approval — we did not approve any transfer,” the company said in a statement.
6d
Philstar.com on MSNMVP: Two cornerstone investors eye Maynilad IPOMaynilad Water Services Inc. chairman Manuel V. Pangilinan said two cornerstone investors are keen on securing a significant ...
Robinhood brings tokenized shares in SpaceX and OpenAI to Europe – without the companies' consent. Is this democratization or ...
Whether to invest in Figma will depend on the company's valuation once it goes public. Figma has a number of attractive ...
Meesho, a cost-effective e-commerce platform, has taken a significant step towards going public by filing its confidential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results